White Matter Disease and Dementia

1996 ◽  
Vol 31 (2) ◽  
pp. 250-268 ◽  
Author(s):  
Stephen M. Rao
Rheumatology ◽  
2020 ◽  
Author(s):  
Yung-Wen Cheng ◽  
Hsiang-Cheng Chen ◽  
Sin-Yi Lyu ◽  
Yao-Feng Li ◽  
Chun-Chi Lu

2016 ◽  
pp. 13-14
Author(s):  
Saltanat Kamenova ◽  
Aida Kondybayeva ◽  
Assiya Akanova

2020 ◽  
Vol 16 (S5) ◽  
Author(s):  
Blake R. Neyland ◽  
Christina E. Hugenschmidt ◽  
Samuel N. Lockhart ◽  
Stephanie Okonmah‐Obazee ◽  
Kiran Solingapuram Sai ◽  
...  

2020 ◽  
Author(s):  
Matthew D. Keefe ◽  
Haille E. Soderholm ◽  
Hung-Yu Shih ◽  
Tamara J. Stevenson ◽  
Kathryn A. Glaittli ◽  
...  

AbstractVanishing White Matter disease (VWM) is a severe leukodystrophy of the central nervous system caused by mutations in subunits of the eukaryotic initiation factor 2B complex (eIF2B). Current models only partially recapitulate key disease features, and pathophysiology is poorly understood. Through development and validation of zebrafish (Danio rerio) models of VWM, we demonstrate that zebrafish eif2b mutants phenocopy VWM, including impaired somatic growth, early lethality, impaired myelination, loss of oligodendrocyte precursor cells, increased apoptosis in the CNS, and impaired motor swimming behavior. Expression of human EIF2B2 in the zebrafish eif2b2 mutant rescues lethality and CNS apoptosis, demonstrating conservation of function between zebrafish and human. In the mutants, intron 12 retention leads to expression of a truncated eif2b5 transcript. Expression of the truncated eif2b5 in wild-type larva impairs motor behavior and activates the ISR, suggesting that a feed-forward mechanism in VWM is a significant component of disease pathophysiology.


Sign in / Sign up

Export Citation Format

Share Document